[MO28] Mini-Oral Session 28　Rare Cancer / Cancer of Unknown Primary 2（Miscellaneous）
【E】

[MO28-5] Clinical utility of comprehensive genomic profiling for patients with cancer of unknown primary site

^○Ryo Kudo¹, Yoshihito Kano^1,2, Rika Noji¹, Ryota Kakuta¹, Iichiro Onishi³, Kouichiro Kimura⁴, Kousuke Tanimoto⁵, Fuyuki Miya^6,12, Takahiro Mitsumura⁷, Noriko Oshima⁸, Yousuke Ariizumi⁹, Tsuyoshi Nakagawa¹⁰, Toshiaki Ishikawa¹¹, Satoshi Miyake², Sadakatsu Ikeda¹ (1.Department of Precision Cancer Medicine, Center for Innovative Cancer Treatment, Tokyo Medical and Dental University, 2.Department of Clinical Oncology, Tokyo Medical and Dental University, 3.Department of Pathology, Tokyo Medical and Dental University, 4.Department of Radiology, Diagnostic Radiology, Tokyo Medical and Dental University, 5.Medical Research Institute, Genome Laboratory, Tokyo Medical and Dental University, 6.Medical Research Institute, Department of Medical Science Mathematics, Tokyo Medical and Dental University, 7.Department of Pulmonary Medicine, Tokyo Medical and Dental University, 8.Department of Obstetrics and Gynecology, Tokyo Medical and Dental University, 9.Department of Head and Neck Surgery, Tokyo Medical and Dental University, 10.Department of Breast Surgery, Tokyo Medical and Dental University, 11.Department of Chemotherapy and Oncosurgery, Tokyo Medical and Dental University, 12.Center for Medical Genetics, Keio University School of Medicine)